Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Human Factors

Date Submitted: Jun 28, 2024
Open Peer Review Period: Jul 1, 2024 - Aug 26, 2024
Date Accepted: Aug 26, 2024
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

Development of a Digital Health Intervention for the Secondary Prevention of Cardiovascular Disease (INTERCEPT): Co-Design and Usability Testing Study

Gibson I, Neubeck L, Corcoran M, Morland C, Donavan S, Jones J, Costello C, Hynes L, Harris A, Harahill M, Lillis M, Atrey A, Ski CF, Savickas V, Byrne M, Murphy AW, McEvoy JW, Wood D, Jennings C

Development of a Digital Health Intervention for the Secondary Prevention of Cardiovascular Disease (INTERCEPT): Co-Design and Usability Testing Study

JMIR Hum Factors 2024;11:e63707

DOI: 10.2196/63707

PMID: 39441626

PMCID: 11541151

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Co-design and usability testing in the development of a digital health intervention for the secondary prevention of cardiovascular disease: The INTERCEPT Study

  • Irene Gibson; 
  • Lis Neubeck; 
  • Marissa Corcoran; 
  • Chris Morland; 
  • Steve Donavan; 
  • Jennifer Jones; 
  • Caroline Costello; 
  • Lisa Hynes; 
  • Aisling Harris; 
  • Mary Harahill; 
  • Mary Lillis; 
  • Alison Atrey; 
  • Chantel F Ski; 
  • Vilius Savickas; 
  • Molly Byrne; 
  • Andrew W Murphy; 
  • John William McEvoy; 
  • David Wood; 
  • Catriona Jennings

ABSTRACT

Background:

Secondary prevention is an important strategy to reduce the burden of cardiovascular disease (CVD), a leading cause of death worldwide. Despite the growing evidence for the effectiveness of digital health interventions (DHI) for the secondary prevention of CVD, the majority are designed with minimal input from target end users, resulting in poor uptake and usage.

Objective:

The objective of this study was to optimise the acceptance and effectiveness of a DHI for the secondary prevention of (CVD) through co-design, integrating end-users perspectives throughout.

Methods:

A theory driven, person-based approach using co-design was adopted for the development of the DHI, known as INTERCEPT. This involved a four-phase iterative process using online workshops. In phase one, a stakeholder team of healthcare professionals, software developers and public and patient involvement members was established. Phase two involved identification of the guiding principles, content and design features of the DHI. In phase three, DHI prototypes were reviewed for clarity of language, ease of navigation and functionality. To anticipate and interpret DHI usage, phase four involved usability testing with participants who had a recent cardiac event (<2 years). Improvements in usability of the DHI were assessed pre- and post-acceptance testing with the System Usability Scale (SUS). The ‘Guidance for reporting intervention development studies in health research’ (GUIDED) checklist was used to report the development process.

Results:

Five key design principles were identified: simplicity and ease of use; behavioural change through goal setting and self-monitoring; personalisation; system credibility and social support. Usability testing resulted in 64 recommendations for the app of which 51 were implemented. Significant improvements in SUS scores were observed comparing before and after implementation of recommendations (61 vs 83, P=.02).

Conclusions:

Combining both behaviour change theory with a person based, co-design approach facilitated the development of a DHI for the secondary prevention of CVD that optimsed responsiveness to end-users needs and preferences, thereby potentially improving future engagement.


 Citation

Please cite as:

Gibson I, Neubeck L, Corcoran M, Morland C, Donavan S, Jones J, Costello C, Hynes L, Harris A, Harahill M, Lillis M, Atrey A, Ski CF, Savickas V, Byrne M, Murphy AW, McEvoy JW, Wood D, Jennings C

Development of a Digital Health Intervention for the Secondary Prevention of Cardiovascular Disease (INTERCEPT): Co-Design and Usability Testing Study

JMIR Hum Factors 2024;11:e63707

DOI: 10.2196/63707

PMID: 39441626

PMCID: 11541151

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.